Product Specifications
| Catalog Number | BIC-2160E |
|---|---|
| Target | Fibroblast growth factor 8 |
| Target Symbol | FGF8 |
| Species | Human |
| Expression System | E.coli |
| Expression Region | Gln23-Arg215 |
| Molecular Weight | 22.4 kDa |
| Purity | ≥95%, by SDS-PAGE (under reducing (R) & Non-reducing conditions, visualized by Coomassie staining). |
| Endotoxin | ≤10 EU/mg by the LAL method. |
| Formulation | Lyophilized |
| Buffer | Lyophilized from a 0.22 μm-filtered solution containing 10 mM PB, 5% Trehalose and 0.01% Tween 80, pH7.4. |
| Reconstitution | It is recommended to redissolve in sterile deionized water. |
| Storage & Stability | 36 months at -20°C to -80°C in lyophilized state; 6 months at -20°C to -80°C under sterile conditions after reconstitution; 7-10 days at 2°C to 8°C under sterile conditions after reconstitution; Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
| Shipping | The product is shipped with blue ice. |
| Lead Time | Products are in stock, but custom products may require further consultation. |
| Accession | P55075.3 |
Bioactivity
Measured in a cell proliferation assay using NlH3T3 cells. The ED50 is ≤1.0 ng/mL.
Quality Data
Recombinant Human FGF-8b (Cat. No. BIC-2160E) was analyzed by SDS-PAGE.
Highly consistent bioactivity between different production batches of Recombinant Human FGF-8b (Cat. No. BIC-2160E) .
